1. Home
  2. NYC vs IRIX Comparison

NYC vs IRIX Comparison

Compare NYC & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Strategic Investment Co.

NYC

American Strategic Investment Co.

N/A

Current Price

$8.41

Market Cap

23.5M

Sector

Finance

ML Signal

N/A

Logo IRIDEX Corporation

IRIX

IRIDEX Corporation

HOLD

Current Price

$1.32

Market Cap

23.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NYC
IRIX
Founded
2013
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.5M
23.0M
IPO Year
2014
1996

Fundamental Metrics

Financial Performance
Metric
NYC
IRIX
Price
$8.41
$1.32
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.7K
33.6K
Earning Date
01-01-0001
04-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
8.47
EPS
N/A
N/A
Revenue
N/A
$41,593,000.00
Revenue This Year
$8.40
$9.61
Revenue Next Year
$1.62
$8.12
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.03
$0.78
52 Week High
$16.30
$1.65

Technical Indicators

Market Signals
Indicator
NYC
IRIX
Relative Strength Index (RSI) 46.61 47.22
Support Level $7.12 $1.33
Resistance Level $10.33 $1.56
Average True Range (ATR) 0.33 0.07
MACD 0.03 -0.01
Stochastic Oscillator 45.90 39.39

Price Performance

Historical Comparison
NYC
IRIX

About NYC American Strategic Investment Co.

American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.

About IRIX IRIDEX Corporation

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

Share on Social Networks: